|
|
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Feb 08, 2024 |
Title |
LMO3 is a suppressor of the basal-like/squamous PDAC subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing
|
Summary |
Pancreatic cancer is a heterogenous disease and consists of distinct subtypes. Here, we searched for candidate suppressor genes of the basal-like/squamous subtype, a more aggressive molecular subtype of pancreatic ductal adenocarcinoma (PDAC). Through an integrated transcriptome analysis, we identified the LMO3, as being downregulated in the basal-like/squamous PDAC using a discovery and validation approach. LMO3 downregulation associated with decreased patient survival. The goal of this study was aimed to identify LMO3 induced molecular signatures in PDAC.
|
|
|
Overall design |
RNA was isolated from PDAC cell lines (n = 8 Panc 10.05_Ctrl vs LMO3) using TRIzol method. The mRNA profiles of the above human PDAC cell lines were generated by deep sequencing using Illumina NextSeq.
|
|
|
Contributor(s) |
Yuuki O, Amanda J. C, Huaitian L, Shouhui Y, Paloma M, Tiffany H. D, Helen C, Azadeh A, Jochen G, Michael G, Nader H, Stefan A, S Perwez H |
Citation(s) |
38366633 |
|
Submission date |
Oct 31, 2023 |
Last update date |
Apr 30, 2024 |
Contact name |
Stefan Ambs |
E-mail(s) |
ambss@mail.nih.gov
|
Phone |
240-760-6836
|
Organization name |
NCI
|
Department |
CCR
|
Lab |
LHC
|
Street address |
Building 37, Room 3050B
|
City |
Bethesda |
State/province |
MD |
ZIP/Postal code |
20892-4258 |
Country |
USA |
|
|
Platforms (1) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
|
Samples (8)
|
|
Relations |
BioProject |
PRJNA1034082 |
Supplementary file |
Size |
Download |
File type/resource |
GSE246660_RawCountFile_rsemgenes_LMO3.txt.gz |
765.1 Kb |
(ftp)(http) |
TXT |
SRA Run Selector |
Raw data are available in SRA |
|
|
|
|
|